Literature DB >> 8290406

A risk-benefit analysis for the treatment of hypertension.

C J Bulpitt1.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8290406      PMCID： PMC2399968          DOI： 10.1136/pgmj.69.816.764

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  23 in total

1.  Randomised trial of treatment of hypertension in elderly patients in primary care.

Authors:  J Coope; T S Warrender
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-01

2.  Quality of life evaluation of antihypertensive drugs.

Authors:  C J Bulpitt; A E Fletcher
Journal:  Pharmacoeconomics       Date:  1992-02       Impact factor: 4.981

3.  The fate of women with normal coronary arteriograms and chest pain resembling angina pectoris.

Authors:  E B Waxler; D Kimbiris; L S Dreifus
Journal:  Am J Cardiol       Date:  1971-07       Impact factor: 2.778

4.  Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial.

Authors:  A Amery; W Birkenhäger; P Brixko; C Bulpitt; D Clement; M Deruyttere; A De Schaepdryver; C Dollery; R Fagard; F Forette
Journal:  Lancet       Date:  1985-06-15       Impact factor: 79.321

5.  The effects of verapamil and propranolol on quality of life in hypertension.

Authors:  A E Fletcher; P C Chester; C M Hawkins; A N Latham; L A Pike; C J Bulpitt
Journal:  J Hum Hypertens       Date:  1989-04       Impact factor: 3.012

6.  The effects of antihypertensive therapy on the quality of life.

Authors:  S H Croog; S Levine; M A Testa; B Brown; C J Bulpitt; C D Jenkins; G L Klerman; G H Williams
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

7.  The effect of treatment on mortality in "mild" hypertension: results of the hypertension detection and follow-up program.

Authors: 
Journal:  N Engl J Med       Date:  1982-10-14       Impact factor: 91.245

8.  Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial.

Authors:  L Wilhelmsen; G Berglund; D Elmfeldt; T Fitzsimons; H Holzgreve; J Hosie; P E Hörnkvist; K Pennert; J Tuomilehto; H Wedel
Journal:  J Hypertens       Date:  1987-10       Impact factor: 4.844

9.  Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60.

Authors:  A Amery; W Birkenhäger; R Brixko; C Bulpitt; D Clement; M Deruyttere; A De Schaepdryver; C Dollery; R Fagard; F Forette
Journal:  Lancet       Date:  1986-09-13       Impact factor: 79.321

Review 10.  Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.

Authors:  R Collins; R Peto; S MacMahon; P Hebert; N H Fiebach; K A Eberlein; J Godwin; N Qizilbash; J O Taylor; C H Hennekens
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321
View more
  2 in total

Review 1.  The Hypertension in the Very Elderly Trial (HYVET). Rationale, methodology and comparison with previous trials.

Authors:  C J Bulpitt; A E Fletcher; A Amery; J Coope; J G Evans; S Lightowlers; K O'Malley; A Palmer; J Potter; P Sever
Journal:  Drugs Aging       Date:  1994-09       Impact factor: 3.923

Review 2.  Goals of antihypertensive therapy.

Authors:  G E McVeigh; J Flack; R Grimm
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.